Neuro-Oncology Reviews
Volume
26 Number 14
20 July 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 14, 20 July
Pichardo-Rojas PS, Pichardo-Rojas D,
Marín-Castañeda LA, Palacios-Cruz M, Rivas-Torres
YI, Calderón-Magdaleno LF, Sánchez-Serrano CD,
Chandra A, Dono A, Karschnia P, Tonn JC, Esquenazi Y.
Prognostic
value of surgical resection over biopsy in elderly patients with
glioblastoma: a meta-analysis.
J
Neurooncol. 2024 Jul 11. doi:
10.1007/s11060-024-04752-w. PMID:
38990444. Meta-analysis˰
ˍ
Del
Baldo G, Carai A, Mastronuzzi A.
Chimeric
antigen receptor adoptive immunotherapy in central nervous system
tumors: state of the art on clinical trials, challenges, and
emerging strategies to addressing them.
Curr
Opin Oncol.
2024 Jul 12. doi:
10.1097/CCO.0000000000001076. PMID:
38989708. Review. ˍ
Bou-Gharios J, Noël G, Burckel H.
Preclinical
and clinical advances to overcome hypoxia in glioblastoma
multiforme.
Cell
Death Dis. 2024 Jul 13;15(7):503. doi:
10.1038/s41419-024-06904-2. PMID:
39003252.
Review. ˍ
Habibi MA, Ghorbani M, Esmaeilian S, Tajvidi F, Nekutalaban P,
Boskabadi AR, Alemi F, Zafari R, Mirjani MS, Eazi S, Minaee P.
Stereotactic radiosurgery versus
combined stereotactic radiosurgery and bevacizumab for recurrent
glioblastoma; a systematic review and meta-analysis of survival.
Neurosurg
Rev. 2024 Jul 13;47(1):323. doi:
10.1007/s10143-024-02585-9. PMID:
39002028. Review; Meta-analysis˰
ˍ
Sanikommu S, Panchawagh S, Eatz T, Lu VM, Rodrigues PB, Abdelsalam
A, Gurses ME, Cummings A, Uppalapati V, Akurati S, Kondoor V,
Komotar RJ, Ivan ME.
Recurrence of
atypical and anaplastic intracranial Meningiomas: A meta-analysis
of risk factors.
Clin
Neurol Neurosurg. 2024 Jul 14;244:108450. doi:
10.1016/j.clineuro.2024.108450. PMID:
39018991. Meta-analysis˰
ˍ
Park JE, Park YW, Kim YH, Song SW, Hong CK, Kim JH, Kim HS.
Determining Progressive Disease Using
RANO 2.0-Further Clarifications and Explanations.
Korean
J Radiol. 2024 Jul 15. doi:
10.3348/kjr.2024.0476. PMID:
39028016. Comment. ˍ
RELATED
ARTICLE
*Won SE, Suh CH, Kim S, Park HJ, Kim KW.
Summary
of Key Points of the Response Assessment in Neuro-Oncology (RANO)
2.0.
Korean
J Radiol.
2024 Apr 11. doi:
10.3348/kjr.2024.0016. PMID:
38627876. Editorial. ˍ
Schiff D.
Low-Grade Gliomas: A New
Mutation, New Targeted Therapy, and Many Questions.
Neurology.
2024 Jul 15;103(3):e209688. doi: 10.1212/WNL.0000000000209688.
PMID: 39008801. Review˰
ˍ
Zhao B, Yao L, Hatami M, Ma W, Skutella T.
Vaccine-based
immunotherapy and related preclinical models for glioma.
Trends
Mol Med. 2024 Jul 15:S1471-4914(24)00167-9. doi:
10.1016/j.molmed.2024.06.009. PMID:
39013724. Review. ˍ
Chai X, Zhang Y, Zhang W, Feng K, Jiang Y, Zhu A, Chen X, Di L,
Wang R.
Tumor Metabolism: A New Field
for the Treatment of Glioma.
Bioconjug
Chem. 2024 Jul 16. doi:
10.1021/acs.bioconjchem.4c00287. PMID:
39013195. Review˰ ˍ
Power
EA, Millesi E, Rechberger JS, Daniels DJ.
CAR-T
cells for H3K27-altered diffuse midline gliomas: where do we
stand?
Immunotherapy.
2024 Jul 17:1-4. doi:
10.1080/1750743X.2024.2373043. PMID:
39016046. Editorial˰ ˍ
Senger
S, Radtke K, Oertel J.
Full
Endoscopic Transcranial Resection of Meningiomas.
Adv
Tech Stand Neurosurg.
2024 Jul 18;52:129-138. doi:
10.1007/978-3-031-61925-0_10. PMID:
39017791. Review; Book chapter˰ ˍ
Lin MD, Tsai AC, Abdullah KG, McBrayer SK, Shi DD.
Treatment
of IDH-mutant glioma in the INDIGO era.
NPJ
Precis Oncol. 2024 Jul 19;8(1):149. doi:
10.1038/s41698-024-00646-2. PMID:
39025958. Review. ˍ
Kamel R, Van den Berge D.
Radiotherapy
for subependymal giant cell astrocytoma: time to challenge a
historical ban? A case report and review of the literature.
J
Med Case Rep. 2024 Jul 20;18(1):330. doi:
10.1186/s13256-024-04649-2. PMID:
39030575. Case report; Review. ˍ